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Abstract
Purpose: Reports on percutaneous embolization of vesicourethral anastomotic fistula are limited. 
Case presentation: A 59-year-old male presented with persistent contained vesicourethral fistula following low anterior 
resection and radical retropubic prostectomy for rectal cancer. A contained fistula with urinary leakage of 350 ml/day 
through a Jackson-Pratt (JP) tube was found at the posterior aspect of the vesicourethral anastomotic site on cystog-
raphy. After 1 month of failed conventional urinary drainage manoeuvre, percutaneous embolization of the contained 
fistula was successfully performed through the JP tube. An Amplatzer vascular plug (AVP) was used to block the 
fistula and N-butyl-2-cyanoacrylate (NBCA) was used to obliterate the urinoma cavity. Computed tomography scans 
at 1-month and 1-year follow-ups showed stable AVP position and complete obliteration of the cavity by NBCA.
Conclusions: The contained vesicourethral anastomotic fistula was successfully managed with AVP and NBCA via a JP 
drainage tube. It is expected that AVP will block the fistula and NBCA will obliterate the urinoma cavity effectively. 
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Introduction 
One of the most common complications of radical pros-
tatectomy following vesicourethral anastomosis is urinary 
leakage, which has an incidence of 0.3% to 15.4% [1]. 
The healing of urinary leakage is usually self-limited and 
resolves in 2 or 3 days postoperatively [2]. However, in 
cases with persistent urinary leakage, urinary diversion or 
ureteral stenting is primarily considered. If these mano-
euvres fail, occlusion of the fistulous tract is recommend-
ed because surgical repair may be challenging [2,3].
Endourologic or percutaneous approaches using a va-
riety of devices and embolic agents have been used as 
minimally invasive treatments for postoperative urinary 
leakage [4,5]. Coils and N-butyl-2-cyanoacrylate (NBCA) 
are frequently used as embolic agents [6], and the most 
common routes for treating anastomotic leakage are per-
cutaneous antegrade access or retrograde access through 
the urethra [3,6,7]. However, reports on the use of pre-
existing Jackson-Pratt (JP) drainage tubes as the access for 
embolization are limited.
We present a case of vesicourethral anastomotic leak-
age embolization with an Amplatzer vascular plug (AVP) 
and NBCA through a JP drainage tube, in which the AVP 
was expected to block the anastomotic fistula and NBCA 
was expected to obliterate the urinoma cavity.
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Case presentation 
A 59-year-old male with rectal cancer invading the 
prostate and urinary bladder underwent low anterior re-
section and radical retropubic proctectomy 15 months 
ago. One month later, the patient presented with persis-
tent urinary leakage at the posterior aspect of the vesico-
urethral anastomotic site, which was confirmed by cysto-
graphy (Figure 1). The amount of urinary leakage through 
the JP drainage tube was 350 ml/day, and its nature was 
urine. Although the indwelling Foley catheter was re-
tained for 1 month, the fistula persisted without infection. 
At the time of interventional procedure consultation, 
there were 2 JP drainage tubes near the vesicourethral 
anastomosis, 1 of which was later changed with a short 
65 cm 5 Fr Kumpe (Cook Medical, Bloomington, IN, 
USA) over a stiff guidewire (180 cm, Glidewire Terumo, 
Tokyo, Japan). The fistula consisted of a single moderately 
sized defect. Because embolization with coils carries a sig-
nificant risk of migration, embolization with an AVP de-
vice was preferred. After the bladder was negotiated with 
a stiff guidewire, a short 8 Fr sheath with a radiopaque 
marker (Boston Scientific, Marlborough, MA, USA) was 
inserted into the bladder. The Foley catheter was clamped 
to retain contrast agent within the bladder, which helped 
in the identification of the fistula. Then, the AVP (type II, 
12 mm diameter, 9 mm long; St. Jude Medical, Plymouth, 
MN, USA) was inserted across the fistula. The Kumpe 
catheter with side holes (by needle punching) was then 
inserted through the sheath into the urinoma cavity. 
The urine in the urinoma cavity was aspirated, and the 
contrast agent was readily delivered through the catheter. 
After flushing with D5W (5% dextrose), the cavity was 
obliterated with 3 vials of NBCA (Histoacryl; B.Braun 
AG, Melsungen, Germany) mixed at a ratio of 1 : 1 with 
ethiodised oil (Lipiodol; Guerber, Vellepinte, France). 
The cavity seemed to have been well-obliterated (Figure 2). 
Cystography carried out 4 days after embolization 
showed the NBCA density and AVP (obscured by over-
lapped NBCA) at the anastomotic site without contrast 
agent leakage (Figure 3). CT scans acquired at 1-month 
and 1-year follow-ups showed stable AVP position and 
complete obliteration of the cavity by NBCA (Figure 4).
Discussion
Persistent vesicourethral anastomotic leakage is a signifi-
cant loss of urine, usually above 100 or 200 ml, after the 
third day postoperatively. The prevalence of persistent vesi-
courethral anastomotic leakage is low, and there are only 
a few published cases reporting that the leakage is difficult 
to control and increases the possibility of extended hospital 
stay in addition to the risk of other complications [8-10].
Figure 1. Cystography (A) and axial computed tomography scan (B) 1 month after prostatectomy. Contrast agent leakage (arrows) is shown at the posterior 
aspect of the vesicourethral anastomotic site on the left side
Figure 2. Radiograph (supine position) after embolization of the contained 
vesicourethral fistula. The fistula was embolized with an Amplatzer vascu-
lar plug (arrow), and the urinoma cavity was embolized with N-butyl-2- 
cyanoacrylate (asterisk) through the JP drainage tube
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Vesicourethral anastomotic leakage is primarily diag-
nosed by the presence of contrast agent extravasation in 
conventional cystography. However, CT scans can provide 
more information, especially with 3-dimensional volume 
estimates, which allows better delineation of the size and 
configuration of the fistula and cavity for determining 
treatment details [11,12]. 
Treatment of vesicourethral anastomotic leakage is 
challenging, and this complication can indefinitely pro-
long the hospitalization period and add the risk of adverse 
events such as secondary infection by resistant germs [8]. 
Approaches for managing this leakage include proximal 
or distal urinary diversion, endoscopy, laparoscopic or 
open surgical repair, and minimally invasive techniques. 
The application of NBCA has recently been reported 
in different branches of surgery as well as for the mana-
gement of urinary fistulas [3-7]. NBCA is a strong tissue- 
adhesive material that can seal the wall of urinoma cavi-
ties and consequently obliterate the space of urine accu-
mulation [6]. A sealant (Glubran 2™) composed of NBCA 
monomer and metacryloxysulpholane monomer showed 
good biocompatibility and progressive reabsorption with-
Figure 4. One-year follow-up axial computed tomography (CT) scans. Serial CT scans showing stable Amplatzer vascular plug position (arrows) and complete 
cavity obliteration by N-butyl-2-cyanoacrylate (arrowheads)
A B
Figure 3. Cystography 4 days after embolization. Radiographs without (A) and with (B) contrast agent injection showing the Amplatzer vascular plug (arrow, 
obscured by N-butyl-2-cyanoacrylate) and N-butyl-2-cyanoacrylate (arrowheads) at the anastomotic site without contrast agent leakage
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out causing foreign body granulomas, and it has shown 
high success rates with few complications in several clini-
cal series [6,7]. 
AVP was approved for use in endovascular emboliza-
tion of medium-to-large vessels as an alternative to coils 
and detachable balloons. Accordingly, several nonvascular 
applications of the AVP have been described, including 
the treatment of bronchopleural fistulas and, only recently, 
urinary tract fistulas [13-15]. In our current case, AVP 
was used to block urine flow as much as possible to the 
urinoma cavity because the urine flow pressure is known 
to be low.
The urethra is commonly used as an access to a vesi-
courethral anastomotic fistula, but cavity obliteration may 
be difficult after fistula embolization. If the guidewire can 
reach the fistula through the cavity, cavity obliteration 
would be easy after fistula embolization; therefore, consid-
ering that surgical drains are used as an alternative route 
for postoperative abdominal abscess [16], surgical drains 
such as a JP drainage tube may also be used as a viable 
alternative to the urethra. As shown in our case, if the 
urinoma cavity is contrasted with a contrast agent through 
the JP drainage tube, the guidewire may be able to access 
the anastomotic fistula through the JP drainage tube.
Conclusions 
A contained vesicourethral anastomotic fistula was success-
fully managed with AVP and NBCA by accessing through 
a JP drainage tube. AVP successfully blocked the fistula, 
and NBCA effectively obliterated the urinoma cavity.
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